Skip to main content

Table 3 Baseline Characteristics of COVID-19 patients with different levels of HDL-C

From: Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study

  Low HDL-C
(n = 46)
High HDL-C
(n = 182)
P value
Sex (male/female) 32/14 83/99 0.004
Age, median (IQR), y 46.0 (37.8, 59.0) 45.0 (35.0, 61.0) 0.795
Comorbidity
 Hypertension (n, %) 9 (19.57) 27 (14.84) 0.432
 Cardiovascular disease (n, %) 1 (2.17) 8 (4.40) 0.789
 Diabetes (n, %) 5 (10.87) 10 (5.49) 0.327
   Chronic liver disease (n, %) 5 (10.87) 7 (3.85) 0.124
Symptoms
 Fever (n, %) 38 (82.61) 135 (74.18) 0.232
 Pharyngalgia (n, %) 5 (10.87) 29 (15.93) 0.389
 Cough (n, %) 41 (89.13) 146 (80.22) 0.160
 Expectoration (n, %) 24 (52.17) 81 (44.51) 0.351
 Dyspnea (n, %) 20 (43.48) 60 (32.97) 0.182
    Hemoptysis (n, %) 3 (6.52) 4 (2.20) 0.298
 Chills (n, %) 5 (10.87) 24 (13.19) 0.673
 Myalgia (n, %) 6 (13.04) 18 (9.89) 0.724
 Fatigue (n, %) 24 (52.17) 82 (45.05) 0.387
 Dizziness (n, %) 3 (6.52) 26 (14.29) 0.158
 Headache (n, %) 1 (2.17) 30 (16.48) 0.011
 Diarrhea (n, %) 11 (23.91) 41 (22.53) 0.841
 Nausea (n, %) 2 (4.35) 28 (15.38) 0.048
 Anorexia (n, %) 26 (56.52) 88 (48.35) 0.322
 Vomiting (n, %) 4 (8.70) 21 (11.54) 0.581
 Abdominal pain (n, %) 1 (2.17) 6 (3.30) 1.000
Chest CT positive rate (n, %) 46 (100.0) 172 (94.51) 0.221
Chest CT with ground-glass change (n, %) 20 (43.48) 88 (48.35) 0.554
Severe cases (n, %) 17 (36.96) 27 (14.84) 0.001
Length of hospital stay, median (IQR), days 13.0 (11.0, 22.5) 16.0 (11.0, 25.0) 0.712
Virus shedding duration, median (IQR), days 17.0 (13.5, 24.0) 18.0 (13.0, 26.0) 0.269
Mortality (n, %) 1 (2.17) 1 (0.55) 0.364
  1. P < 0.05 was considered statistically significant (marked in bold)
  2. COVID-19 Coronavirus disease 2019; HDL-C High density lipoprotein cholesterol; IQR Inter-quartile range